Global Biologics and Biosimilars Market Report 2021
At the beginning of 2020, COVID-19 disease began to spread around the world, millions of people worldwide were infected with COVID-19 disease, and major countries around the world have implemented foot prohibitions and work stoppage orders. Except for the medical supplies and life support products industries, most industries have been greatly impacted, and Biologics and Biosimilars industries have also been greatly affected.
In the past few years, the Biologics and Biosimilars market experienced a growth of 0.103078660737, the global market size of Biologics and Biosimilars reached 3072.0 million $ in 2020, of what is about 1881.0 million $ in 2015.
From 2015 to 2019, the growth rate of global Biologics and Biosimilars market size was in the range of xxx%. At the end of 2019, COVID-19 began to erupt in China, Due to the huge decrease of global economy; we forecast the growth rate of global economy will show a decrease of about 4%, due to this reason, Biologics and Biosimilars market size in 2020 will be 3072.0 with a growth rate of xxx%. This is xxx percentage points lower than in previous years.
As of the date of the report, there have been more than 20 million confirmed cases of CVOID-19 worldwide, and the epidemic has not been effectively controlled. Therefore, we predict that the global epidemic will be basically controlled by the end of 2020 and the global Biologics and Biosimilars market size will reach 4575.0 million $ in 2025, with a CAGR of xxx% between 2020-2025.
This Report covers the manufacturers’ data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.
Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers.
Section 1: Free——Definition
Section (2 3): 1200 USD——Manufacturer Detail
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
United Laboratories
Section 4: 900 USD——Region Segmentation
North America Country (United States, Canada)
South America
Asia Country (China, Japan, India, Korea)
Europe Country (Germany, UK, France, Italy)
Other Country (Middle East, Africa, GCC)
Section (5 6 7): 500 USD——
Product Type Segmentation
Antibody
Hormone
Growth Factors
Other
Industry Segmentation
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
Channel (Direct Sales, Distributor) Segmentation
Section 8: 400 USD——Trend (2020-2025)
Section 9: 300 USD——Product Type Detail
Section 10: 700 USD——Downstream Consumer
Section 11: 200 USD——Cost Structure
Section 12: 500 USD——Conclusion
Section 1 Biologics and Biosimilars Product Definition
Section 2 Global Biologics and Biosimilars Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Biologics and Biosimilars Shipments
2.2 Global Manufacturer Biologics and Biosimilars Business Revenue
2.3 Global Biologics and Biosimilars Market Overview
2.4 COVID-19 Impact on Biologics and Biosimilars Industry
Section 3 Manufacturer Biologics and Biosimilars Business Introduction
3.1 Roche Biologics and Biosimilars Business Introduction
3.1.1 Roche Biologics and Biosimilars Shipments, Price, Revenue and Gross profit 2015-2020
3.1.2 Roche Biologics and Biosimilars Business Distribution by Region
3.1.3 Roche Interview Record
3.1.4 Roche Biologics and Biosimilars Business Profile
3.1.5 Roche Biologics and Biosimilars Product Specification
3.2 Amgen Biologics and Biosimilars Business Introduction
3.2.1 Amgen Biologics and Biosimilars Shipments, Price, Revenue and Gross profit 2015-2020
3.2.2 Amgen Biologics and Biosimilars Business Distribution by Region
3.2.3 Interview Record
3.2.4 Amgen Biologics and Biosimilars Business Overview
3.2.5 Amgen Biologics and Biosimilars Product Specification
3.3 AbbVie Biologics and Biosimilars Business Introduction
3.3.1 AbbVie Biologics and Biosimilars Shipments, Price, Revenue and Gross profit 2015-2020
3.3.2 AbbVie Biologics and Biosimilars Business Distribution by Region
3.3.3 Interview Record
3.3.4 AbbVie Biologics and Biosimilars Business Overview
3.3.5 AbbVie Biologics and Biosimilars Product Specification
3.4 Sanofi-Aventis Biologics and Biosimilars Business Introduction
3.5 Johnson & Johnson Biologics and Biosimilars Business Introduction
3.6 Pfizer Biologics and Biosimilars Business Introduction
…
Section 4 Global Biologics and Biosimilars Market Segmentation (Region Level)
4.1 North America Country
4.1.1 United States Biologics and Biosimilars Market Size and Price Analysis 2015-2020
4.1.2 Canada Biologics and Biosimilars Market Size and Price Analysis 2015-2020
4.2 South America Country
4.2.1 South America Biologics and Biosimilars Market Size and Price Analysis 2015-2020
4.3 Asia Country
4.3.1 China Biologics and Biosimilars Market Size and Price Analysis 2015-2020
4.3.2 Japan Biologics and Biosimilars Market Size and Price Analysis 2015-2020
4.3.3 India Biologics and Biosimilars Market Size and Price Analysis 2015-2020
4.3.4 Korea Biologics and Biosimilars Market Size and Price Analysis 2015-2020
4.4 Europe Country
4.4.1 Germany Biologics and Biosimilars Market Size and Price Analysis 2015-2020
4.4.2 UK Biologics and Biosimilars Market Size and Price Analysis 2015-2020
4.4.3 France Biologics and Biosimilars Market Size and Price Analysis 2015-2020
4.4.4 Italy Biologics and Biosimilars Market Size and Price Analysis 2015-2020
4.4.5 Europe Biologics and Biosimilars Market Size and Price Analysis 2015-2020
4.5 Other Country and Region
4.5.1 Middle East Biologics and Biosimilars Market Size and Price Analysis 2015-2020
4.5.2 Africa Biologics and Biosimilars Market Size and Price Analysis 2015-2020
4.5.3 GCC Biologics and Biosimilars Market Size and Price Analysis 2015-2020
4.6 Global Biologics and Biosimilars Market Segmentation (Region Level) Analysis 2015-2020
4.7 Global Biologics and Biosimilars Market Segmentation (Region Level) Analysis
Section 5 Global Biologics and Biosimilars Market Segmentation (Product Type Level)
5.1 Global Biologics and Biosimilars Market Segmentation (Product Type Level) Market Size 2015-2020
5.2 Different Biologics and Biosimilars Product Type Price 2015-2020
5.3 Global Biologics and Biosimilars Market Segmentation (Product Type Level) Analysis
Section 6 Global Biologics and Biosimilars Market Segmentation (Industry Level)
6.1 Global Biologics and Biosimilars Market Segmentation (Industry Level) Market Size 2015-2020
6.2 Different Industry Price 2015-2020
6.3 Global Biologics and Biosimilars Market Segmentation (Industry Level) Analysis
Section 7 Global Biologics and Biosimilars Market Segmentation (Channel Level)
7.1 Global Biologics and Biosimilars Market Segmentation (Channel Level) Sales Volume and Share 2015-2020
7.2 Global Biologics and Biosimilars Market Segmentation (Channel Level) Analysis
Section 8 Biologics and Biosimilars Market Forecast 2020-2025
8.1 Biologics and Biosimilars Segmentation Market Forecast (Region Level)
8.2 Biologics and Biosimilars Segmentation Market Forecast (Product Type Level)
8.3 Biologics and Biosimilars Segmentation Market Forecast (Industry Level)
8.4 Biologics and Biosimilars Segmentation Market Forecast (Channel Level)
Section 9 Biologics and Biosimilars Segmentation Product Type
9.1 Antibody Product Introduction
9.2 Hormone Product Introduction
9.3 Growth Factors Product Introduction
9.4 Other Product Introduction
Section 10 Biologics and Biosimilars Segmentation Industry
10.1 Tumor Clients
10.2 Diabetes Clients
10.3 Cardiovascular Clients
10.4 Hemophilia Clients
10.5 Other Clients
Section 11 Biologics and Biosimilars Cost of Production Analysis
11.1 Raw Material Cost Analysis
11.2 Technology Cost Analysis
11.3 Labor Cost Analysis
11.4 Cost Overview
Section 12 Conclusion
Chart and Figure
Figure Biologics and Biosimilars Product Picture from Roche
Chart 2015-2020 Global Manufacturer Biologics and Biosimilars Shipments (Units)
Chart 2015-2020 Global Manufacturer Biologics and Biosimilars Shipments Share
Chart 2015-2020 Global Manufacturer Biologics and Biosimilars Business Revenue (Million USD)
Chart 2015-2020 Global Manufacturer Biologics and Biosimilars Business Revenue Share
Chart Roche Biologics and Biosimilars Shipments, Price, Revenue and Gross profit 2015-2020
Chart Roche Biologics and Biosimilars Business Distribution
Chart Roche Interview Record (Partly)
Figure Roche Biologics and Biosimilars Product Picture
Chart Roche Biologics and Biosimilars Business Profile
Table Roche Biologics and Biosimilars Product Specification
Chart Amgen Biologics and Biosimilars Shipments, Price, Revenue and Gross profit 2015-2020
Chart Amgen Biologics and Biosimilars Business Distribution
Chart Amgen Interview Record (Partly)
Figure Amgen Biologics and Biosimilars Product Picture
Chart Amgen Biologics and Biosimilars Business Overview
Table Amgen Biologics and Biosimilars Product Specification
Chart AbbVie Biologics and Biosimilars Shipments, Price, Revenue and Gross profit 2015-2020
Chart AbbVie Biologics and Biosimilars Business Distribution
Chart AbbVie Interview Record (Partly)
Figure AbbVie Biologics and Biosimilars Product Picture
Chart AbbVie Biologics and Biosimilars Business Overview
Table AbbVie Biologics and Biosimilars Product Specification
3.4 Sanofi-Aventis Biologics and Biosimilars Business Introduction
…
Chart United States Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart United States Biologics and Biosimilars Sales Price ($/Unit) 2015-2020
Chart Canada Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Canada Biologics and Biosimilars Sales Price ($/Unit) 2015-2020
Chart South America Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart South America Biologics and Biosimilars Sales Price ($/Unit) 2015-2020
Chart China Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart China Biologics and Biosimilars Sales Price ($/Unit) 2015-2020
Chart Japan Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Japan Biologics and Biosimilars Sales Price ($/Unit) 2015-2020
Chart India Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart India Biologics and Biosimilars Sales Price ($/Unit) 2015-2020
Chart Korea Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Korea Biologics and Biosimilars Sales Price ($/Unit) 2015-2020
Chart Germany Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Germany Biologics and Biosimilars Sales Price ($/Unit) 2015-2020
Chart UK Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart UK Biologics and Biosimilars Sales Price ($/Unit) 2015-2020
Chart France Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart France Biologics and Biosimilars Sales Price ($/Unit) 2015-2020
Chart Italy Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Italy Biologics and Biosimilars Sales Price ($/Unit) 2015-2020
Chart Europe Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Europe Biologics and Biosimilars Sales Price ($/Unit) 2015-2020
Chart Middle East Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Middle East Biologics and Biosimilars Sales Price ($/Unit) 2015-2020
Chart Africa Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Africa Biologics and Biosimilars Sales Price ($/Unit) 2015-2020
Chart GCC Biologics and Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart GCC Biologics and Biosimilars Sales Price ($/Unit) 2015-2020
Chart Global Biologics and Biosimilars Market Segmentation (Region Level) Sales Volume 2015-2020
Chart Global Biologics and Biosimilars Market Segmentation (Region Level) Market size 2015-2020
Chart Biologics and Biosimilars Market Segmentation (Product Type Level) Volume (Units) 2015-2020
Chart Biologics and Biosimilars Market Segmentation (Product Type Level) Market Size (Million $) 2015-2020
Chart Different Biologics and Biosimilars Product Type Price ($/Unit) 2015-2020
Chart Biologics and Biosimilars Market Segmentation (Industry Level) Market Size (Volume) 2015-2020
Chart Biologics and Biosimilars Market Segmentation (Industry Level) Market Size (Share) 2015-2020
Chart Biologics and Biosimilars Market Segmentation (Industry Level) Market Size (Value) 2015-2020
Chart Global Biologics and Biosimilars Market Segmentation (Channel Level) Sales Volume (Units) 2015-2020
Chart Global Biologics and Biosimilars Market Segmentation (Channel Level) Share 2015-2020
Chart Biologics and Biosimilars Segmentation Market Forecast (Region Level) 2020-2025
Chart Biologics and Biosimilars Segmentation Market Forecast (Product Type Level) 2020-2025
Chart Biologics and Biosimilars Segmentation Market Forecast (Industry Level) 2020-2025
Chart Biologics and Biosimilars Segmentation Market Forecast (Channel Level) 2020-2025
Chart Antibody Product Figure
Chart Antibody Product Advantage and Disadvantage Comparison
Chart Hormone Product Figure
Chart Hormone Product Advantage and Disadvantage Comparison
Chart Growth Factors Product Figure
Chart Growth Factors Product Advantage and Disadvantage Comparison
Chart Other Product Figure
Chart Other Product Advantage and Disadvantage Comparison
Chart Tumor Clients
Chart Diabetes Clients
Chart Cardiovascular Clients
Chart Hemophilia Clients
Chart Other Clients
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|